Data as of Q4 2025 (Dec 31, 2025)

Whitefort Capital Management, LP

•CIK: 1884931•Filing: Q4 2025

**Whitefort Capital Management, LP** manages $371M across a concentrated portfolio of 19 positions. The fund exhibits significant conviction in select names, with I9DN representing the largest holding at $64.2M. Top allocations also include PFG ($46.0M), BALY ($31.7M), and MRNA ($29.5M). This structure suggests a focused, high-conviction approach targeting outsized returns within its chosen sectors.

Total AUM
$318.0M
+ $40.2M in options
QoQ Performance
+7.0%
Positions
16
+ 2 options
Top 10 Concentration
86.8%
Latest Filing
Q4 2025

Top Holdings Allocation

I9DN
ROIV
BALY
MRNA
OABI
JOYY
TDAY
GNW
I9DN17.9%
ROIV12.8%
BALY8.9%
MRNA8.2%
OABI7.3%
JOYY7.3%
TDAY6.9%
GNW6.4%

📈 Biggest Buys

MRNAPUT
MODERNA INC
NEW
8.2% of portfolio
SOC
SABLE OFFSHORE CORP
NEW
4.8% of portfolio
QURE
UNIQURE NV
NEW
3.1% of portfolio
BALY
BALLYS CORPORATION
+43.0%
8.9% of portfolio
TDAY
USA TODAY CO INC
+33.2%
6.9% of portfolio

📉 Biggest Sells

ROIV
ROIVANT SCIENCES LTD
-40.0%
12.8% of portfolio
LQDA
LIQUIDIA CORPORATION
-74.0%
1.5% of portfolio
GNW
GENWORTH FINL INC
-31.4%
6.4% of portfolio
XCY
OPKO HEALTH INC
-13.2%
1.5% of portfolio

Sector Breakdown

Other100.0%

🚪 Exited Positionssold since Q3 2025

SPY
SPDR S&P 500 ETF TR
SOLD
$26.6M
GSL
GLOBAL SHIP LEASE INC NEW
SOLD
$9.3M
IWM
ISHARES TR
SOLD
$8.0M
TRIB
TRINITY BIOTECH PLC
SOLD
$53.2K

Changes from Q3 2025

NEW3 new positions
↑3 increased
↓4 decreased

Historical Filings

Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

📌 Top Holdings

I9DN17.9%
ARBUTUS BIOPHARMA CORP
$64.2M
ROIV12.8%
ROIVANT SCIENCES LTD
$46.0M
BALY8.9%
BALLYS CORPORATION
$31.7M
MRNA8.2%
MODERNA INC
$29.5M
OABI7.3%
OMNIAB INC
$26.3M

⚖️ Compare Fund

Compare this fund's holdings with other hedge funds.

🎯 Fund Movement Signals

See AI-analyzed fund movement signals and accumulation patterns.

👤 Insider Trading

See what corporate insiders are buying and selling.